A novel navigated doxorubicin delivery formulation to breast cancer therapy

Breast cancer (BC) is the most frequently diagnosed cancer and leading cause of the death in women. Current chemotherapy usually results in poor prognosis with low treatment efficacy and high side effects because of weak targeting specificity and fast elicitation of multidrug resistance (MDR). It is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sinan Cheng, Zheng Lu, Yang Feng, Xuewei Zhao, Ruixia Zhao, Zuchun Qiu, Chenshuang Jia, Lirong Chen, Yue Yuan, Xinyao Li, Qian Gao, Jie Xu, Zhan Shu, Wei Duan, Li Xiao, Guochao Nie, Yingchun Hou
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2022-06-01
Col·lecció:Materials Today Advances
Matèries:
Breast cancer
Targeted drug delivery
Doxorubicin
Multidrug resistance
Accés en línia:http://www.sciencedirect.com/science/article/pii/S2590049822000315
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars